The Food and Drug Administration granted market clearance for Innovative Health Solutions' nerve stimulation device Wednesday.
The NSS-2 Bridge device is intended to treat opioid withdrawal symptoms, such as nausea, vomiting and abdominal pain. A patient may wear the device behind their ear for up to five days.
"Significantly reducing withdrawal symptoms lessens the dependency on opioids, allows for easier transition to medically assisted treatment and ultimately works as another tool to combat the opioid epidemic facing our country," said Brian Carrico, president of IHS.
More articles on opioids:
Former Insys CEO to plead not guilty in opioid scheme indictment
Indianapolis files opioid epidemic lawsuit against drugmakers, drug distributors
40+ state AGs call for repeal of law stifling DEA's oversight of opioid distributors